ZA882957B - Omega-quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal anti-inflammatory drugs - Google Patents

Omega-quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal anti-inflammatory drugs

Info

Publication number
ZA882957B
ZA882957B ZA882957A ZA882957A ZA882957B ZA 882957 B ZA882957 B ZA 882957B ZA 882957 A ZA882957 A ZA 882957A ZA 882957 A ZA882957 A ZA 882957A ZA 882957 B ZA882957 B ZA 882957B
Authority
ZA
South Africa
Prior art keywords
thioesters
omega
quaternary ammonium
alkyl esters
inflammatory drugs
Prior art date
Application number
ZA882957A
Other languages
English (en)
Inventor
Michael Charles Venuti
Charles Venuti Michael
John Maitland Young
Maitland Young John
Original Assignee
Syntex Pharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Pharma Int filed Critical Syntex Pharma Int
Publication of ZA882957B publication Critical patent/ZA882957B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA882957A 1987-04-27 1988-04-26 Omega-quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal anti-inflammatory drugs ZA882957B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4307287A 1987-04-27 1987-04-27

Publications (1)

Publication Number Publication Date
ZA882957B true ZA882957B (en) 1989-12-27

Family

ID=21925341

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882957A ZA882957B (en) 1987-04-27 1988-04-26 Omega-quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal anti-inflammatory drugs

Country Status (4)

Country Link
EP (1) EP0289262A3 (fr)
JP (1) JPS6452742A (fr)
AU (1) AU1508988A (fr)
ZA (1) ZA882957B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662521B2 (ja) * 1988-02-24 1994-08-17 日東紡績株式会社 新規コリン誘導体及びそれを用いた血清コリンエステラーゼ活性測定法
IL89848A (en) * 1988-04-07 1997-08-14 Sepracor Chiral ester derivatives
AU4534593A (en) * 1992-06-12 1994-01-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
DE4300697C1 (de) * 1993-01-13 1994-05-19 Roemmers Sa Keterolac-Derivat mit wesentlich geringerer gastrointestinaler Reizung und Ulzeration
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
US7361680B2 (en) 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US6545034B1 (en) 1999-07-23 2003-04-08 The Regents Of The University Of California Use of etodolac for the treatment of chronic lymphocytic leukemia
US7129262B2 (en) 1999-07-23 2006-10-31 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7151100B1 (en) 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
CA2419060A1 (fr) * 2000-08-09 2002-02-14 The Regents Of The University Of California Composes indoliques utilises dans le traitement du cancer
US7601846B2 (en) 2001-06-26 2009-10-13 The Regents Of The University Of California Compounds having activity as inhibitors of apoptosis
WO2004026116A2 (fr) 2002-09-19 2004-04-01 The Regents Of The University Of California Utilisation d'etodoclac aux fins de traitement de l'hyperplasie
WO2008020270A1 (fr) * 2006-08-15 2008-02-21 Techfields Biochem Co. Ltd Promédicaments hydrosolubles chargés positivement contenant des acides aryl- et hétéroarylpropioniques et dotés d'une très grande vitesse de pénétration cutanée
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
WO2008012605A1 (fr) * 2006-07-27 2008-01-31 Techfields Biochem Co. Ltd Promédicaments hydrosolubles à charge positive de kétoprofène et composés associés à vitesse de pénétration cutanée très rapide
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
JP5144658B2 (ja) * 2006-07-18 2013-02-13 テックフィールズ バイオケム カンパニー リミテッド イブプロフェンの正荷電水溶性プロドラッグ
AU2013231152B2 (en) * 2006-07-18 2016-06-09 Techfields Biochem Co. Ltd Positively charged water-soluble pro-drugs of ibuprofen
CN101500982A (zh) * 2006-07-25 2009-08-05 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性双氯芬酸前药
CN104622858B (zh) * 2006-07-27 2019-08-30 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性酮洛芬及相关化合物的前药
CN104610077B (zh) * 2006-07-27 2020-04-14 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性酮洛芬及相关化合物的前药
CN103705496B (zh) * 2006-08-15 2017-03-01 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的芳基和杂芳基丙酸类前药
AU2013206218B2 (en) * 2006-08-15 2016-06-30 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate
PL2084132T3 (pl) * 2006-09-03 2019-03-29 Techfields Biochem Co. Ltd Dodatnio naładowane rozpuszczalne w wodzie proleki z kwasów n-arylantranilowych z bardzo szybką penetracją skóry
CN104706630B (zh) * 2006-09-03 2020-01-10 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药
CN105669531B (zh) * 2007-06-04 2019-05-07 于崇曦 具有快速皮肤和生物膜穿透速度的非甾体抗炎药的前药及其新的医药用途
CN105820107B (zh) 2007-06-04 2022-09-09 泰飞尔公司 具有快速皮肤和生物膜穿透速度的非甾体抗炎药的前药及其新的医药用途
US20170044096A1 (en) 2013-03-15 2017-02-16 Rutgers, The State University Of New Jersey Augmenting Moieties for Anti-Inflammatory Compounds
US20120010168A1 (en) 2008-11-03 2012-01-12 Jeffrey Laskin Unique Dual-Action Therapeutics
US11731991B2 (en) 2008-11-03 2023-08-22 Lehigh University Augmenting moieties for anti-inflammatory compounds
KR102225999B1 (ko) 2008-12-04 2021-03-10 충시 위 고투과력을 가진 조성물 및 이의 적용
CN101434567B (zh) * 2008-12-19 2012-10-24 李扬 一种二乙氨基乙硫醇的制备方法
EP2653463B1 (fr) * 2012-04-20 2014-06-25 Rohm and Haas Company Hydrophobe Dibenzylamine
MX2014013910A (es) 2012-05-16 2015-06-04 Techfields Pharma Co Ltd Composiciones de profarmacos de alta penetracion y composiciones farmaceuticas de los mismos para el tratamiento de afecciones pulmonares.
JP5629745B2 (ja) * 2012-10-23 2014-11-26 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚透過率を有するアリール−及びヘテロアリールプロピオン酸の正荷電水溶性プロドラッグ
JP5940036B2 (ja) * 2013-10-08 2016-06-29 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚透過率を有するアリール−及びヘテロアリールプロピオン酸の正荷電水溶性プロドラッグ
CN104876848B (zh) * 2015-05-15 2017-05-17 南开大学 一种1‑酰基‑3‑吲哚硫酯化合物及其制备方法
JP6290947B2 (ja) * 2016-02-05 2018-03-07 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚透過率を有するアリール−及びヘテロアリールプロピオン酸の正荷電水溶性プロドラッグ

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390555A (en) * 1943-08-03 1945-12-11 Poythress William P & Co Antispasmodic agents
FR1052419A (fr) * 1951-03-17 1954-01-25 Sterling Drug Inc Procédé perfectionné de préparation de composés organiques nouveaux
FR3354M (fr) * 1962-12-15 1965-06-08 Lemoine Jean Philippe Nouveaux agents antispasmodiques et parasympatholytiques.
CA1012159A (en) * 1972-06-27 1977-06-14 Michael Marx Dialkylaminoalkyl esters of 2-(6-methoxy-2-naphthyl) propionic acid and the pharmaceutically acceptable salts thereof
AR206619A1 (es) * 1974-02-07 1976-08-06 Hexachimie Procedimiento para peparar acidos 5-indanilaceticos
EP0180416A3 (fr) * 1984-10-30 1986-11-20 Takeda Chemical Industries, Ltd. Dérivés de l'acide benzoique et leur production
IT1208736B (it) * 1986-03-04 1989-07-10 Sigma Tau Ind Farmaceuti Alogenuri dell'estere del 2-n,n,n,dimetil-alchil-amminoetanolo con acido acetico variamente sostituito e composizioni farmaceutiche che licontengono ad attivita' antiinfiammatoria e antisettica

Also Published As

Publication number Publication date
JPS6452742A (en) 1989-02-28
EP0289262A2 (fr) 1988-11-02
AU1508988A (en) 1988-10-27
EP0289262A3 (fr) 1989-05-31

Similar Documents

Publication Publication Date Title
ZA882957B (en) Omega-quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal anti-inflammatory drugs
HK26696A (en) Preparation of clavulanic acid and its salts and esters
IL92545A0 (en) Preparation of 2-chloropyridine-3-carboxylic acid esters
JPS6416783A (en) Bridged diazabicycloalkylquinolinecarboxylic acid and esters of same
IL78533A (en) Esters of 2-diazo-3-siloxyalkenoic acids and their preparation
NZ216971A (en) Phosphonate esters and pharmaceutical compositions
AU1846488A (en) Analgesic and anti-inflammatory thiourea derivatives
NZ216894A (en) Penicillin derivatives and pharmaceutical compositions
ZA862985B (en) 7-amino-3-propenylcephalosporanic acid and esters thereof
ZA869694B (en) Azoniaspironortropanol esters and their pharmaceutical use
NZ215587A (en) 3-oxoandrost-4-ene-17beta-carboxylic acid ester derivatives and pharmaceutical compositions
AU1258988A (en) Esters of oxalofluoride
GB8712909D0 (en) Preparation of esters
EP0200311A3 (en) Preparation process of alpha-l-aspartyl-l-phenylalanine methyl ester or hydrochloride thereof
EP0216324A3 (en) 4-alkoxy-3-pyrrolin-2-on-1-yl-acetic acid alkyl esters and their preparation
AU582678B2 (en) Heterocyclylalkyl esters of 2-imidazolinonenicotinic acids
JPS6416790A (en) 6-substituted peneem ester as anti-inflammatory drug and anti-modifying agent
NZ217724A (en) Esters of dihydrolysergic acid and pharmaceutical composition
NZ216946A (en) Penicillin derivatives and pharmaceutical compositions
PH22354A (en) Alkoxy and dialkoxyalkyl esters of dihydrolysergic
ZA867418B (en) Esters of dihydrolysergic acid
DE3266707D1 (en) Preparation of nitroarylacetic acid esters and derivatives thereof
GB2241238B (en) Methyl esters of aryl-keto acid
ZA8548B (en) Esters of 4'-haloanthracyclines
ZA8549B (en) Esters of 4'-deoxyanthracyclines